Mass General and the Phil Smith Neuroscience Institute at Holy Cross Hospital will host the South Florida Neuroscience Symposium on February 7 - 8, 2020.

This symposium is a 2 day educational and networking forum designed for physicians,nurses, advanced practitioners, pharmacists, allied health professionals, researchers,and students with a focus on the emerging science of genetic therapies and theevaluation, management, and treatment of Alzheimer's Disease, ALS, brain tumors and metastases, and stroke.

Attendees will be eligible for CME credit and will focus on the following learning objectives:

  • Identification of clinical syndromes and understanding of diagnostic considerations
  • Development of awareness of clinical management of Alzheimer’s Disease, ALS, brain tumors and metastases, and stroke
  • Identification of resources available to support patients and caregivers
  • Discussion of new and proven therapies forneurodegenerative diseases
  • Discussion of novel therapeutic targets witha focus on neuro inflammation across neurodegenerative diseases

Featured speakers include faculty and staff from the Massachusetts General Hospital Department of Neurology and Healey Center for ALS, as well as Holy Cross Hospital, University of Miami and Catholic Health Services.

The first day of the symposium will focus on ALS, with session titles like "Living at Home with ALS" and "Training the Lungs: How and Why." The second day will cover neurosciences more broadly, and will feature sessions on genetic therapy, minimally-invasive brain tumor treatment, and stroke. The keynote speakers will be Mass General Neurology Chief Merit Cudkowicz, MD, MSc, and Eduardo Locatelli, MD, MPH, director of the Phil Smith Neuroscience Institute.

To learn more and register, visit southfloridaneurosciences.com.